<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Evaluation of pulmonary symptoms in persons with HIV
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Evaluation of pulmonary symptoms in persons with HIV
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Evaluation of pulmonary symptoms in persons with HIV
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Diane E Stover, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Talmadge E King, Jr, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Roy M Gulick, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jennifer Mitty, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 12, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The acquired immunodeficiency syndrome (AIDS) epidemic remains one of the most important global health problems of the 21st century [
         <a href="#rid1">
          1-4
         </a>
         ]. Although the incidence of AIDS-related opportunistic infections declined dramatically in the United States and Europe following the introduction of potent antiretroviral therapy (ART), pulmonary disease remains a significant cause of morbidity and mortality [
         <a href="#rid5">
          5-8
         </a>
         ].
        </p>
        <p>
         This topic will focus on the evaluation of persons with HIV who present with pulmonary symptoms; specific conditions and their management are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3704.html" rel="external">
          "Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8018.html" rel="external">
          "Epidemiology of tuberculosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3714.html" rel="external">
          "Toxoplasma pneumonia and other parasitic pulmonary infections in patients with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/111683.html" rel="external">
          "Diagnosis of pulmonary tuberculosis in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          CAUSES OF PULMONARY DISEASE IN PERSONS WITH HIV
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are a variety of infectious and noninfectious pulmonary diseases that are more likely to be seen in persons with HIV. The immune reconstitution syndrome can also affect the lung and mimic other conditions, such as various infections and even lung cancer [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3762.html" rel="external">
          "Immune reconstitution inflammatory syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2383046319">
         <span class="h2">
          Infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         The spectrum of pulmonary disease in individuals with HIV has changed over the past decades [
         <a href="#rid5">
          5-7,10
         </a>
         ]. Although
         <em>
          Pneumocystis
         </em>
         pneumonia (PCP) remains the most common AIDS-defining opportunistic infection in the United States, its incidence has decreased with improved prophylactic and antiretroviral therapy (ART). (See
         <a class="medical medical_review" href="/z/d/html/3704.html" rel="external">
          "Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV"
         </a>
         .)
        </p>
        <p>
         Persons with HIV are at risk for a number of other pulmonary infections in addition to PCP. Bacterial pneumonia remains a common complication in patients with HIV and has increased as a proportion of diagnosed pulmonary infections despite an overall decrease in the number of cases [
         <a href="#rid11">
          11,12
         </a>
         ]. A detailed discussion of bacterial pulmonary infections in patients with HIV is presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3716.html" rel="external">
          "Bacterial pulmonary infections in patients with HIV"
         </a>
         .)
        </p>
        <p>
         In addition to bacterial pneumonia, many people with HIV have coinfection with tuberculosis (TB), especially in resource-limited countries. In Africa, TB is the most common pulmonary complication of HIV, and at least one-third of all cases occur in patients with HIV [
         <a href="#rid13">
          13
         </a>
         ]. In addition, infection caused by endemic fungi and parasites contributes substantially to the morbidity and mortality of this population worldwide. (See
         <a class="medical medical_review" href="/z/d/html/8018.html" rel="external">
          "Epidemiology of tuberculosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3714.html" rel="external">
          "Toxoplasma pneumonia and other parasitic pulmonary infections in patients with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/111683.html" rel="external">
          "Diagnosis of pulmonary tuberculosis in adults"
         </a>
         .)
        </p>
        <p>
         Viral pathogens also contribute to the burden of pulmonary disease in patients with HIV. In one report of persons with HIV from Africa, where the seroprevalence of cytomegalovirus (CMV) is high, retinitis, pneumonia, and colitis were the most commonly reported manifestations of CMV [
         <a href="#rid14">
          14
         </a>
         ]. CMV coinfection in these individuals was associated with more HIV transmission and increased mortality. The clinical significance, however, of isolating CMV from respiratory secretions remains controversial. (See
         <a class="medical medical_review" href="/z/d/html/8305.html" rel="external">
          "Approach to the diagnosis of cytomegalovirus infection"
         </a>
         .)
        </p>
        <p>
         Non-PCP fungal pneumonia (eg, coccidioidomycosis, histoplasmosis, cryptococcus) has become less common following improvements in antiretroviral treatment, but its true incidence remains unknown. (See
         <a class="medical medical_review" href="/z/d/html/2418.html" rel="external">
          "Management considerations, screening, and prevention of coccidioidomycosis in immunocompromised individuals and pregnant patients", section on 'Patients with HIV'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6991.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of histoplasmosis in patients with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2421.html" rel="external">
          "Cryptococcus neoformans infection outside the central nervous system"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H162139454">
         <span class="h2">
          Noninfectious pulmonary diseases
         </span>
         <span class="headingEndMark">
          —
         </span>
         The use of potent ART has been associated with a reduction in certain noninfectious pulmonary complications. As an example, the incidence of Kaposi sarcoma has declined, most likely as a result of immune reconstitution, although it still remains one of the most common neoplasms in patients with HIV [
         <a href="#rid15">
          15
         </a>
         ]. In addition, the use of ART has contributed to a decrease in the incidence of non-Hodgkin lymphoma and also in the overall incidence of AIDS-related lymphoma [
         <a href="#rid16">
          16,17
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8035.html" rel="external">
          "HIV infection and malignancy: Epidemiology and pathogenesis"
         </a>
         .)
        </p>
        <p>
         Despite these improvements associated with ART, some noninfectious pulmonary diseases, such as lung cancer, Hodgkin lymphoma, constrictive bronchiolitis, and bronchiectasis, are on the rise [
         <a href="#rid18">
          18,19
         </a>
         ]. HIV is also cited as a risk factor for the development of emphysema, independent of cigarette smoking. Among other factors, HIV infection may affect cytotoxic lymphocyte activation and capillary endothelial cell injury and apoptosis, leading to destruction of lung parenchyma [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         Organizing pneumonia, sarcoidosis, drug hypersensitivity, primary effusion lymphoma, foreign body granulomatosis, and other forms of lung disease can occasionally develop in patients with HIV [
         <a href="#rid21">
          21-30
         </a>
         ]. Lymphocytic interstitial pneumonitis, a rare interstitial lung disease in the general population, has declined with increased access to ART. (See
         <a class="medical medical_review" href="/z/d/html/4752.html" rel="external">
          "Primary effusion lymphoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4361.html" rel="external">
          "Lymphoid interstitial pneumonia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          CLINICAL ASSESSMENT
         </span>
        </p>
        <p class="headingAnchor" id="H1114479338">
         <span class="h2">
          History
         </span>
         <span class="headingEndMark">
          —
         </span>
         When evaluating a patient with HIV and pulmonary symptoms it is important to obtain a careful history of their immune status (eg, CD4 count, history of opportunistic infections), when their current symptoms began, the nature of the symptoms, and associated findings. As an example, patients with
         <em>
          Pneumocystis
         </em>
         pneumonia (PCP) typically have a subacute onset of dyspnea and cough, whereas patients with bacterial pneumonia often have an acute onset of fever and cough. (See
         <a class="medical medical_review" href="/z/d/html/3704.html" rel="external">
          "Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV", section on 'Clinical Features of Pulmonary disease'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3716.html" rel="external">
          "Bacterial pulmonary infections in patients with HIV", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
         Epidemiologic and environmental considerations are also important. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A detailed assessment of any possible exposure to active tuberculosis (TB) is an important part of the medical history. Some cases of TB in patients with HIV represent newly acquired infection rather than reactivation of old disease. Risk factors for TB may include recent or remote travel to an endemic country. In addition, health care facilities, prisons, and homeless shelters are potential sources for transmission of TB. (See
         <a class="medical medical_review" href="/z/d/html/8018.html" rel="external">
          "Epidemiology of tuberculosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/111683.html" rel="external">
          "Diagnosis of pulmonary tuberculosis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There is an increased incidence of pulmonary histoplasmosis and coccidioidomycosis in patients who live or travel in endemic areas (the Mississippi River Valley/parts of the Caribbean and the Southwest United States, respectively). Reactivation can occur especially in histoplasmosis; thus, patients who resided or spent time in endemic areas earlier in their lives are at risk for overt disease as they become more immunosuppressed. (See
         <a class="medical medical_review" href="/z/d/html/6991.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of histoplasmosis in patients with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2418.html" rel="external">
          "Management considerations, screening, and prevention of coccidioidomycosis in immunocompromised individuals and pregnant patients", section on 'Patients with HIV'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In addition to infection caused by endemic fungi, parasitic disease results in substantial morbidity and mortality among this population worldwide. Responsible organisms that cause pulmonary disease include
         <em>
          Toxoplasma gondii
         </em>
         and
         <em>
          Strongyloides stercoralis
         </em>
         . (See
         <a class="medical medical_review" href="/z/d/html/3710.html" rel="external">
          "Toxoplasmosis in patients with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3714.html" rel="external">
          "Toxoplasma pneumonia and other parasitic pulmonary infections in patients with HIV"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         Certain diagnostic clues on physical examination are often unrelated to examination of the chest but may suggest a pulmonary diagnosis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The skin can show manifestations of pulmonary-associated bacterial, fungal, viral, or neoplastic disorders. As an example, umbilicated lesions seen in association with headache and fever should prompt a search for cryptococcosis [
         <a href="#rid31">
          31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3757.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of Cryptococcus neoformans meningoencephalitis in patients with HIV"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Examination of the fundus and optic disc may suggest the presence of viral, fungal, or mycobacterial infection. (See
         <a class="medical medical_review" href="/z/d/html/3746.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of AIDS-related cytomegalovirus retinitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7999.html" rel="external">
          "Tuberculosis and the eye"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lymph nodes can be enlarged due to TB, fungal disease, or lymphoma. (See
         <a class="medical medical_review" href="/z/d/html/8386.html" rel="external">
          "Evaluation of peripheral lymphadenopathy in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7026.html" rel="external">
          "Pulmonary tuberculosis: Clinical manifestations and complications", section on 'Patients with HIV infection'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4750.html" rel="external">
          "HIV-related lymphomas: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H843601386">
         <span class="h2">
          HIV status
         </span>
        </p>
        <p class="headingAnchor" id="H3624781431">
         <span class="h3">
          CD4 count
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with HIV, the risk of developing certain infections correlates with the degree of impairment of host defenses. As a result, the CD4 count can provide important information about a patient's susceptibility to specific types of pulmonary disease [
         <a href="#rid32">
          32
         </a>
         ]. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sinusitis and bronchitis can occur at any CD4 count.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bacterial pneumonia and TB can occur at any CD4 cell count and before AIDS-defining opportunistic infections or neoplasms occur. However, both occur more frequently as immune function declines. (See
         <a class="medical medical_review" href="/z/d/html/3716.html" rel="external">
          "Bacterial pulmonary infections in patients with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8018.html" rel="external">
          "Epidemiology of tuberculosis", section on 'HIV infection'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         PCP usually occurs below 200 cells/microL. (See
         <a class="medical medical_review" href="/z/d/html/3704.html" rel="external">
          "Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Disseminated histoplasmosis usually occurs below 150 cells/microL. (See
         <a class="medical medical_review" href="/z/d/html/6991.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of histoplasmosis in patients with HIV"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         More detailed information on the relationship of the CD4 count with the risk of specific infections is presented in separate topic reviews. (See
         <a class="medical medical_review" href="/z/d/html/3724.html" rel="external">
          "The natural history and clinical features of HIV infection in adults and adolescents", section on 'Overview of stages of HIV infection'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3747.html" rel="external">
          "Overview of prevention of opportunistic infections in patients with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3740.html" rel="external">
          "Techniques and interpretation of measurement of the CD4 cell count in people with HIV"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H806587280">
         <span class="h3">
          Antiretroviral therapy history
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients who are not receiving antiretroviral therapy (ART) may be at increased risk for opportunistic infections, particularly those with a low CD4 count. (See
         <a class="local">
          'CD4 count'
         </a>
         above.)
        </p>
        <p>
         By contrast, effective ART results in sustained suppression of HIV RNA, improved cellular immunity (ie, CD4 count), and reduced HIV-immune activation (eg, proinflammatory cytokines, chronic inflammation, and T cell activation), which can otherwise lead to end-organ damage (eg, coronary artery disease, liver and kidney disease, neurologic disease, malignancy). ART also results in both a decreased incidence of HIV-related comorbid conditions and an improvement in outcomes among those who develop a comorbid disease. (See
         <a class="medical medical_review" href="/z/d/html/3724.html" rel="external">
          "The natural history and clinical features of HIV infection in adults and adolescents"
         </a>
         .)
        </p>
        <p>
         In patients presenting with pulmonary disease, it is important to assess when ART was initiated. Patients recently started on ART may develop an immune reconstitution inflammatory syndrome to pathogens or recrudescence of diseases that have been dormant. As an example, patients with latent mycobacterial disease may develop fever, lymphadenopathy, and pulmonary opacities following immune restoration [
         <a href="#rid21">
          21
         </a>
         ]. Immune reconstitution inflammatory syndromes can also occur with other infections, malignancies, or inflammatory syndromes, including PCP, Kaposi sarcoma, and sarcoidosis. (See
         <a class="medical medical_review" href="/z/d/html/3762.html" rel="external">
          "Immune reconstitution inflammatory syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          IMAGING STUDIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Plain chest radiographs, computed tomographic (CT) scans, and (on occasion) nuclear imaging scans all may play a role in the diagnostic evaluation of a patient with HIV and pulmonary symptoms.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Chest radiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Plain chest radiography is an appropriate initial imaging study for patients with HIV who present with unexplained pulmonary or constitutional symptoms. Any new abnormalities, including focal or diffuse opacities, nodules with or without cavitation, pleural effusions, and/or intrathoracic adenopathy, should be pursued for a definitive diagnosis.
        </p>
        <p>
         Certain specific radiographic patterns may assist in this process  (
         <a class="graphic graphic_table graphicRef73151" href="/z/d/graphic/73151.html" rel="external">
          table 1
         </a>
         ). Disease specific considerations include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           Pneumocystis
          </em>
         </strong>
         <strong>
          pneumonia
         </strong>
         – Typical radiographic findings in patients with
         <em>
          Pneumocystis
         </em>
         pneumonia (PCP) include bilateral airspace infiltrates, often characterized as having a finely granular, reticular, or "ground glass" appearance [
         <a href="#rid33">
          33
         </a>
         ]. However, nodular densities, lobar consolidation, cystic lesions, upper lobe opacities, and pneumothoraces can all be seen. Aerosolized
         <a class="drug drug_general" data-topicid="9752" href="/z/d/drug information/9752.html" rel="external">
          pentamidine
         </a>
         prophylaxis appears to increase the probability of an atypical radiographic presentation of PCP infection with cavitation or pneumatocele formation in the upper lobes or periphery due to inadequate deposition of pentamidine into those areas [
         <a href="#rid33">
          33,34
         </a>
         ]. Approximately 10 percent of patients with HIV and PCP have normal chest x-rays. (See
         <a class="medical medical_review" href="/z/d/html/3704.html" rel="external">
          "Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mycobacterial disease
         </strong>
         – Patients with HIV and pulmonary tuberculosis (TB) can present with atypical radiographs. In early studies, postprimary ("typical") patterns, with upper lobe opacification and/or cavitation, were seen in only 20 to 30 percent of patients with pulmonary TB [
         <a href="#rid35">
          35,36
         </a>
         ]. Findings compatible with primary infection, including intrathoracic adenopathy, lower lobe opacities, and/or pleural effusions, were present in up to 35 percent of these patients [
         <a href="#rid35">
          35,36
         </a>
         ]. A subsequent study, comparing the radiographic presentation of HIV-associated TB in the era prior to and after the introduction of potent antiretroviral therapy (ART), found that the incidence of "typical" postprimary chest radiographic changes increased from 25 to 45 percent, respectively [
         <a href="#rid37">
          37
         </a>
         ]. The chest radiograph tends to correlate with the CD4 count; patients with CD4 counts above 200 cells/microL more commonly have a postprimary ("typical") pattern, while patients with CD4 counts below 200 cells/microL tend to have radiographs that are normal or compatible with primary TB infection [
         <a href="#rid38">
          38
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7026.html" rel="external">
          "Pulmonary tuberculosis: Clinical manifestations and complications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         One study found that persons with HIV who had abnormal chest radiographs (including nodules/masses, opacities, cavities, lymphadenopathy, and effusions) and absence of pulmonary symptoms had a high incidence of infectious disorders, especially typical and atypical mycobacterial diseases [
         <a href="#rid39">
          39
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3755.html" rel="external">
          "Mycobacterium avium complex (MAC) infections in persons with HIV"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bacterial pneumonia
         </strong>
         – Opacities localized to a segment or lobe, particularly if they contain air bronchograms, are suggestive of bacterial pneumonia. The probability is even greater when observed in patients with CD4 lymphocyte counts &gt;200 cells/microL. A majority (60 to 90 percent) of patients with HIV who have bacterial pneumonia will have localized opacities. Diffuse opacities have been described, particularly in patients with pneumonia caused by
         <em>
          Haemophilus influenzae
         </em>
         [
         <a href="#rid40">
          40-42
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other infections
         </strong>
         – Patients with advanced HIV are at increased risk of pulmonary and systemic infections, such as
         <em>
          Rhodococcus equi
         </em>
         , a
         <em>
          Nocardia
         </em>
         -like organism associated with cavitary pneumonia and pleuropericardial effusion [
         <a href="#rid43">
          43-45
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5510.html" rel="external">
          "Clinical features, diagnosis, therapy, and prevention of
          <i>
           Rhodococcus equi
          </i>
          infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Chest CT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chest CT scans have become an important part of the diagnostic evaluation of persons with advanced HIV and pulmonary symptoms. Chest CTs are more sensitive than plain chest radiographs in the detection of early interstitial lung disease, lymphadenopathy, and nodules. In a study of patients with HIV who had evidence of pulmonary disease on chest CT, 17 percent had normal findings reported on plain chest radiograph [
         <a href="#rid46">
          46
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6982.html" rel="external">
          "Principles of computed tomography of the chest"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6988.html" rel="external">
          "High resolution computed tomography of the lungs"
         </a>
         .)
        </p>
        <p>
         Chest CT scans have a greater ability than chest radiographs to identify and characterize pulmonary nodules both in patients with and without HIV. Nodules (with or without cavitation) in patients with HIV can result from infection (especially bacterial pneumonia and mycobacterial disease) or malignancy (particularly lymphoma). A biopsy, usually CT-guided transthoracic needle aspirate, is often required to make a definitive diagnosis [
         <a href="#rid47">
          47,48
         </a>
         ].
        </p>
        <p>
         Chest CTs are also helpful in identifying adenopathy. In another study of 318 patients, 35 percent had evidence of lymphadenopathy on CT; typical and atypical mycobacterial disease, bacterial pneumonia, and lymphoma were the most common diagnoses [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
         Certain patterns noted on CT may also lead to a specific diagnosis. As an example, one prospective study evaluated the accuracy of high resolution CT scans (HRCT) in distinguishing between PCP and other causes of lung disease in 30 patients with CD4 counts &lt;200/microL, pulmonary symptoms, and nondiagnostic chest radiographs [
         <a href="#rid50">
          50
         </a>
         ]. The diagnosis "suggestive of PCP" was applied to cases showing a diffuse or ground-glass pattern predominately in the upper lobes with or without cystic changes. Other findings such as "tree in bud" appearance, consolidation, bronchiectasis, and lymphadenopathy were classified as "not suggestive of PCP." The sensitivity and specificity, as well as the positive and negative predictive values of the HRCT for the diagnosis for PCP were 100, 83.3, 90.5, and 100 percent, respectively. A more detailed discussion of HRCT for the diagnosis of PCP is presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3704.html" rel="external">
          "Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV", section on 'Evaluation and diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Nuclear scanning
         </span>
         <span class="headingEndMark">
          —
         </span>
         Various forms of nuclear scanning have been used to evaluate persons with HIV who have pulmonary symptoms:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Although highly sensitive for detecting PCP, gallium citrate (67 gallium) lung scanning has limited utility in the diagnostic evaluation of patients with HIV and pulmonary symptoms since this study is nonspecific. Thus, this test is rarely performed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Kaposi sarcoma is positive on
         <a class="drug drug_general" data-topicid="101540" href="/z/d/drug information/101540.html" rel="external">
          Thallium-201
         </a>
         (TI-201) scans but negative on Gallium citrate (67 gallium) scans. This type of imaging may be helpful in patients when there is no cutaneous disease and lung tissue sampling is not feasible [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Positron emission tomography (PET) scanning has been used to evaluate opportunistic infections or malignancies; however, since false positive scans have been associated with high levels of HIV RNA, PET scanning may not offer significant advantages to other imaging modalities that are not affected by clinical status [
         <a href="#rid52">
          52
         </a>
         ]. In addition, PET scanning cannot differentiate malignancy from infection.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3319599385">
         <span class="h1">
          OTHER TYPES OF TESTING
         </span>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Physiologic studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Physiologic studies, including measurements of pulmonary function and gas exchange, may be useful in the evaluation of patients with HIV and pulmonary symptoms. (See
         <a class="medical medical_review" href="/z/d/html/6969.html" rel="external">
          "Overview of pulmonary function testing in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Pulse oximetry or arterial blood gas analysis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The use of pulse oximetry or arterial blood gases performed before and after exercise can be helpful to identify pulmonary disease in patients with HIV who experience dyspnea or cough, especially when chest radiographs are normal. As an example, investigators found that desaturation below 90 percent (measured by oximetry) occurred in 74 percent of patients with
         <em>
          Pneumocystis
         </em>
         pneumonia (PCP) who rode a bicycle ergometer for 10 minutes [
         <a href="#rid53">
          53
         </a>
         ]. In this study, the best independent predictors of PCP were exercise-induced desaturation (odds ratio [OR] 5.4, 95% CI 2.6-11.3) and infiltrates on chest radiograph (OR 4.9, 95% CI 2.2-10.9); resting arterial hypoxemia was much less predictable. In another report of patients with HIV and documented PCP, an abnormal exercise test showing a marked decrease in the alveolar-to-arterial oxygen difference between rest and exercise was consistent with PCP [
         <a href="#rid54">
          54
         </a>
         ]. By contrast, patients who did not have a decrease in the (A-a) oxygen gradient with exercise were unlikely to have the disorder. (See
         <a class="medical medical_review" href="/z/d/html/1612.html" rel="external">
          "Pulse oximetry"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3709.html" rel="external">
          "Treatment and prevention of Pneumocystis infection in patients with HIV", section on 'Initial assessment'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Diffusing capacity for carbon monoxide
         </span>
         <span class="headingEndMark">
          —
         </span>
         Measurement of the diffusing capacity for carbon monoxide (DLCO) is a sensitive (though nonspecific) marker for pulmonary parenchymal disease [
         <a href="#rid55">
          55
         </a>
         ]. In PCP, the DLCO may decrease before the development of interstitial infiltrates on chest radiograph and in the absence of resting hypoxemia. Thus, when the DLCO is abnormal (&lt;80 percent of predicted) in a symptomatic patient, even with a normal chest radiograph, further diagnostic evaluation is indicated [
         <a href="#rid56">
          56
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6972.html" rel="external">
          "Diffusing capacity for carbon monoxide"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Sputum analysis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Analysis of spontaneously expectorated sputum is used primarily in patients with suspected bacterial infections or tuberculosis (TB). Induced sputum with histologic staining can be used for the diagnosis of PCP. The value of sputum induction and analysis in the setting of other pulmonary infections is unknown.
        </p>
        <p>
         Detailed information on the role of sputum analysis for specific diseases is presented in individual topic reviews:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3716.html" rel="external">
          "Bacterial pulmonary infections in patients with HIV", section on 'Sputum'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/111683.html" rel="external">
          "Diagnosis of pulmonary tuberculosis in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3704.html" rel="external">
          "Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV", section on 'Choosing the optimal respiratory specimen'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6991.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of histoplasmosis in patients with HIV", section on 'Diagnostic evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3672587257">
         <span class="h2">
          Noninvasive tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of noninvasive diagnostic tests have been used in specific clinical settings.
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h3">
          Antibody, antigen, and beta-D-glucan testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Assays designed to detect antigens (eg, urine histoplasma polysaccharide antigen, serum cryptococcal antigen, and serum galactomannan) may be useful for the diagnosis of certain fungal diseases. In addition, elevated plasma levels of 1-3-beta-d-glucan, a component of the cell wall of many fungi, have been found in the setting of invasive aspergillosis and PCP. By contrast, serologic testing is generally of little value in the diagnosis of acute pulmonary infections in patients with HIV. A detailed discussions of these tests are found within the individual topic reviews. (See
         <a class="medical medical_review" href="/z/d/html/2421.html" rel="external">
          "Cryptococcus neoformans infection outside the central nervous system", section on 'Pulmonary infection in immunocompromised adults'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15717.html" rel="external">
          "Diagnosis of invasive aspergillosis", section on 'Diagnostic modalities'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3704.html" rel="external">
          "Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV", section on 'Choosing the diagnostic test'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6991.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of histoplasmosis in patients with HIV", section on 'Approach to diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h3">
          Polymerase chain reaction testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Polymerase chain reaction (PCR) testing is useful for diagnosis of certain infections (eg, viral infections,
         <em>
          Pneumocystis
         </em>
         ).
        </p>
        <p>
         Nasal swabs or washings may be used for the diagnosis of community-acquired viral infections due to influenza, parainfluenza, adenovirus, respiratory syncytial virus, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In a prospective study of 55 patients with HIV and pulmonary symptoms, nearly one-fifth of all patients were positive for at least one respiratory virus including coronavirus, influenza, and parainfluenza [
         <a href="#rid57">
          57
         </a>
         ]. Since no other pathogens were found in the majority of cases, these were felt to be responsible for the pulmonary symptoms. (See
         <a class="medical medical_review" href="/z/d/html/7032.html" rel="external">
          "Clinical evaluation and diagnostic testing for community-acquired pneumonia in adults", section on 'Testing for respiratory viruses'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/128404.html" rel="external">
          "COVID-19: Diagnosis", section on 'NAAT (including RT-PCR)'
         </a>
         .)
        </p>
        <p>
         PCR of respiratory fluid, in particular bronchoalveolar lavage (BAL), is increasingly used to make the diagnosis of PCP [
         <a href="#rid58">
          58
         </a>
         ]. The utility of PCR for the detection of
         <em>
          Pneumocystis
         </em>
         in oral washes and nasopharyngeal aspirates remains controversial [
         <a href="#rid59">
          59
         </a>
         ]. The high sensitivity associated with PCR is its greatest drawback, since cutoff values to distinguish colonization from infection with PCP have not yet been established [
         <a href="#rid59">
          59,60
         </a>
         ]. A more detailed discussion of PCR testing for the diagnosis of PCP is presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3704.html" rel="external">
          "Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV", section on 'Choosing the diagnostic test'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h3">
          Smear and culture of peripheral blood
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cultures of blood for Histoplasma capsulatum and mycobacteria may occasionally provide a definitive diagnosis. In patients with disseminated histoplasmosis, the highest yield is from bone marrow or blood cultures, which are positive in more than 75 percent of cases. Smears of peripheral blood can provide a rapid diagnosis in approximately 28 percent of cases [
         <a href="#rid61">
          61
         </a>
         ]. Mycobacterial blood cultures are positive in 26 to 42 percent of patients with HIV and tuberculosis (TB), and the frequency of positive results is inversely related to the CD4 count [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h3">
          Serum lactate dehydrogenase
         </span>
         <span class="headingEndMark">
          —
         </span>
         Measurement of serum lactate dehydrogenase (LDH) is helpful in screening patients suspected of having PCP. One study of 54 patients with PCP found that 93 percent had an abnormal LDH value [
         <a href="#rid62">
          62
         </a>
         ]. Although LDH is sensitive for the diagnosis of PCP, its specificity is quite low. Thus, a normal LDH value makes the diagnosis unlikely. Other diseases associated with markedly elevated LDH values include lymphoma, TB, and toxoplasmosis. (See
         <a class="medical medical_review" href="/z/d/html/3710.html" rel="external">
          "Toxoplasmosis in patients with HIV"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h3">
          Skin testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         With the exception of the
         <a class="drug drug_general" data-topicid="10029" href="/z/d/drug information/10029.html" rel="external">
          tuberculin skin test
         </a>
         , other skin testing in patients with HIV is not useful. Therapy for latent tuberculosis infection (LTBI) is indicated for patients with HIV who have a positive tuberculin skin test (&gt;5 mm) without active TB [
         <a href="#rid63">
          63
         </a>
         ]. Since the positivity of the tuberculin test depends upon the CD4 count, a negative test in patients with CD4 counts &lt;300 cells/microL does
         <strong>
          not
         </strong>
         rule out either active or latent infection. Tuberculin skin tests should
         <strong>
          not
         </strong>
         be relied upon to make or rule out the diagnosis of active pulmonary TB. A detailed discussion of skin testing and other noninvasive tests (ie, interferon-gamma release assays) for TB screening is found elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/115049.html" rel="external">
          "Tuberculosis infection (latent tuberculosis) in adults: Approach to diagnosis (screening)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h2">
          Invasive tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         On rare occasion, invasive diagnostic tests may be needed to help in the evaluation of patients with HIV and pulmonary disease. The major invasive tests that are used to diagnose pulmonary disease in patients with HIV include fiberoptic bronchoscopy (FOB), CT-guided transthoracic needle aspiration (TTNA), and surgical lung biopsy using either video-assisted thoracoscopic surgery (VATS) or open thoracotomy.
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h3">
          Fiberoptic bronchoscopy
         </span>
         <span class="headingEndMark">
          —
         </span>
         FOB remains the procedure of choice for diagnosing certain pulmonary diseases in patients with HIV because of its high yield and low complication rate [
         <a href="#rid64">
          64
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4400.html" rel="external">
          "Flexible bronchoscopy in adults: Indications and contraindications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4011082333">
         <span class="h4">
          Evaluation of infectious causes
         </span>
         <span class="headingEndMark">
          —
         </span>
         The organisms most commonly identified using FOB include
         <em>
          Pneumocystis jirovecii
         </em>
         (which causes PCP), as well as other fungal, mycobacterial, and viral pathogens. By contrast, FOB is rarely performed for the routine diagnosis of bacterial infection in patients with HIV.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           Pneumocystis
          </em>
         </strong>
         <strong>
          pneumonia
         </strong>
         – The yield of BAL for the diagnosis of PCP is between 96 and 98 percent. Hence, the value of routine transbronchial biopsy in addition to BAL is controversial. Although biopsies slightly increase the risks of pneumothorax and hemorrhage, they may incrementally improve the diagnostic yield in PCP and other infections [
         <a href="#rid65">
          65
         </a>
         ]. If transbronchial biopsy is contraindicated, BAL alone continues to have a good overall diagnostic yield, justifying its use as a sole procedure. (See
         <a class="medical medical_review" href="/z/d/html/4398.html" rel="external">
          "Flexible bronchoscopy in adults: Overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3704.html" rel="external">
          "Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV", section on 'Evaluation and diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tuberculosis
         </strong>
         – The role of FOB in the rapid diagnosis of TB in patients with HIV remains controversial. Several studies have shown that bronchoscopy provided an early diagnosis in patients who had negative sputum smears 34 to 38 percent of the time [
         <a href="#rid66">
          66,67
         </a>
         ]. In one study, transbronchial biopsy provided the exclusive means for rapid diagnosis in 6 of 59 patients with HIV [
         <a href="#rid66">
          66
         </a>
         ]. However, studies directly comparing induced sputum to bronchoscopy have found the yield of induced sputum superior or equal to that of bronchoscopy [
         <a href="#rid68">
          68
         </a>
         ]. If bronchoscopy is to be used for rapid diagnosis of TB, a transbronchial biopsy should be considered in addition to washings and lavage [
         <a href="#rid66">
          66,67
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/111683.html" rel="external">
          "Diagnosis of pulmonary tuberculosis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cytomegalovirus infection
         </strong>
         – The clinical relevance of CMV retrieved bronchoscopically is questionable since BAL culture or cells showing cytopathic changes compatible with CMV in patients with HIV are not specific for CMV pneumonitis or morbidity [
         <a href="#rid69">
          69
         </a>
         ]. In general, treatment is not warranted when CMV is isolated in bronchoscopic specimens from an asymptomatic person (eg, if bronchoscopy was performed for evaluation of noninfectious disorder).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Transbronchial biopsies are more likely to be specific for CMV pneumonitis but are insensitive due to the patchy nature of the disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnostic utility of specific types of testing for CMV include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Culture
         </strong>
         – Cultures of BAL fluid are neither sensitive nor specific for CMV pneumonitis [
         <a href="#rid70">
          70-75
         </a>
         ]. One study of 54 patients with HIV and CMV pneumonitis at autopsy found a sensitivity of BAL culture of only 50 percent [
         <a href="#rid70">
          70
         </a>
         ], while a second study involving 40 autopsies found a sensitivity of 61 percent [
         <a href="#rid71">
          71
         </a>
         ]. The specificity of a positive result also appears unacceptably low, and the presence of CMV on BAL culture does not correlate with gas exchange or chest radiographic abnormalities or with acute morbidity due to pulmonary disease [
         <a href="#rid72">
          72,73
         </a>
         ]. One study of asymptomatic persons with HIV found that BAL culture was positive for CMV in 9 out of 19 subjects (47 percent) [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A particular problem is posed by the coexistence of CMV with other pathogens found in BAL fluid, particularly
         <em>
          P. jirovecii
         </em>
         (the causative agent of PCP). BAL fluid cultures or PCR testing may be positive for CMV in many patients with HIV and PCP [
         <a href="#rid73">
          73
         </a>
         ], but it is not clear that clinical sequelae can be attributed to the presence of CMV [
         <a href="#rid73">
          73,76
         </a>
         ]. In a study of 111 patients with AIDS and a first episode of PCP, 48 percent had CMV demonstrated on BAL fluid culture, but there was no difference between CMV culture-positive and culture-negative patients in terms of initial presentation, long-term survival, hospital mortality, or length of hospital stay [
         <a href="#rid77">
          77
         </a>
         ]. Thus, when CMV is isolated from bronchoscopic specimens and concomitant pathogens are also present, treatment of only the concomitant pathogens is usually recommended.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Polymerase chain reaction testing
         </strong>
         – The usefulness of CMV-PCR testing in BAL fluid has not been fully evaluated in patients with HIV and CMV pneumonitis. In one study of patients without HIV, CMV-PCR-BAL provided significantly higher sensitivity and specificity compared with shell vial cultures and conventional cultures for CMV [
         <a href="#rid78">
          78
         </a>
         ]. However, the use of this test remains controversial.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cytology
         </strong>
         – BAL cytology that is positive for a cytopathic effect is presumably a more specific test than BAL fluid culture or PCR for CMV. However, there is no good correlation of cytopathic effect with either pneumonia attributable to HIV or with morbidity, above and beyond that associated with the presence of a positive BAL culture [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H428930993">
         <span class="h4">
          Evaluation of noninfectious etiologies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchoscopic biopsies can provide tissue specimens allowing diagnosis of noninfectious disorders including Kaposi sarcoma [
         <a href="#rid79">
          79
         </a>
         ], lymphocytic interstitial pneumonitis, and nonspecific interstitial pneumonitis, which cannot be reliably diagnosed on the basis of BAL findings. The diagnostic yield of endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) is high with experienced operators, and it is the preferred diagnostic procedure in patients for thoracic lymphadenopathy and lung cancer staging. (See
         <a class="medical medical_review" href="/z/d/html/4383.html" rel="external">
          "Bronchoscopy: Transbronchial needle aspiration"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4386.html" rel="external">
          "Endobronchial ultrasound: Indications, contraindications, and complications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3562886922">
         <span class="h3">
          Transbronchial lung cryobiopsy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transbronchial lung cryo biopsy has been reported to be a valid and safe alternative to surgical lung biopsy in patients with diffuse parenchymal lung disease (DPLD). The reported diagnostic yield has been between 70 and 80 percent. (See
         <a class="medical medical_review" href="/z/d/html/4407.html" rel="external">
          "Bronchoscopic cryotechniques in adults"
         </a>
         .)
        </p>
        <p>
         Although there are no large studies in persons with HIV, it might be considered a viable alternative to open lung biopsy in those suspected of having noninfectious diffuse pneumonitis and malignancies such as lymphoma, Kaposi sarcoma, lung cancer, and other causes of DPLD [
         <a href="#rid80">
          80
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h3">
          CT-guided TTNA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transthoracic needle aspiration (TTNA) using CT guidance has a high yield in diagnosing the cause of peripheral nodules and localized infiltrates; however, the yield is much lower in patients with diffuse disease. In a study of patients with focal chest or mediastinal abnormalities on CT scan, a diagnosis was established in 27 of 32 cases (84 percent) using TTNA [
         <a href="#rid81">
          81
         </a>
         ]. Although infectious agents were isolated in most of these patients, bronchogenic carcinoma was also diagnosed.
        </p>
        <p>
         Although TTNA has been shown to be a safe and effective procedure for the evaluation of focal thoracic disease, it is not widely used for diffuse/interstitial disease. The reasons for this include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The small size of the samples obtained limits the number of studies that can be performed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The diagnostic yield is lower than that of FOB for the diagnosis of interstitial disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There is a higher complication rate compared to FOB.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H29">
         <span class="h3">
          Surgical lung biopsy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgical lung biopsy remains the procedure with the greatest sensitivity in the diagnosis of parenchymal lung disease. Thoracotomy and VATS can both be performed safely in patients with HIV. One study showed that in patients who had a nondiagnostic bronchoscopy, a definitive diagnosis was found in 13 of 18 patients (72 percent) who underwent open lung biopsy [
         <a href="#rid82">
          82
         </a>
         ]. Another study showed that results of an open lung biopsy led to a change in therapy in 15 of 25 patients, eight of whom improved clinically and were discharged from the hospital [
         <a href="#rid83">
          83
         </a>
         ]. The authors outlined the following indications for open lung biopsy in patients with HIV:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nondiagnostic bronchoscopy
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Failed medical therapy after a diagnostic bronchoscopy
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Failed empiric medical therapy after a nondiagnostic bronchoscopy
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Any of the above, in combination with a worsening chest radiograph
        </p>
        <p>
        </p>
        <p>
         Even though no formal comparison of VATS and open lung biopsy has been made in patients with HIV, both procedures appear to be equivalent for obtaining diagnostic lung tissue. There may be less morbidity associated with VATS, as these patients generally require fewer days in hospital and less time with chest tube drainage [
         <a href="#rid83">
          83
         </a>
         ]. If the patient cannot tolerate single lung ventilation, which is necessary during VATS, or if the lesion cannot be reached through a thoracoscope, then an open thoracotomy should be performed. In general, the choice of procedure is best left to the surgeon. (See
         <a class="medical medical_review" href="/z/d/html/6973.html" rel="external">
          "Preoperative physiologic pulmonary evaluation for lung resection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3237497033">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111612.html" rel="external">
          "Society guideline links: Opportunistic infections in adults with HIV"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H31">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Causes of pulmonary disease
         </strong>
         – Persons with HIV are at increased risk of both infectious and noninfectious pulmonary diseases. Infectious etiologies include bacterial pneumonia, viral pneumonia,
         <em>
          Pneumocystis
         </em>
         pneumonia (PCP), and tuberculosis (TB). Noninfectious pulmonary diseases include lung cancer, Hodgkin lymphoma, constrictive bronchiolitis, bronchiectasis, and emphysema. (See
         <a class="local">
          'Causes of pulmonary disease in persons with HIV'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical assessment
         </strong>
         – When evaluating a patient with HIV and pulmonary disease, attention should be paid to the specific signs and symptoms, likely exposures, physical examination findings, and HIV-associated factors (eg, CD4 cell count, viral load level, and antiretroviral history). (See
         <a class="local">
          'Clinical assessment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Imaging studies
         </strong>
         – Chest radiographs, CT scanning, and (on occasion) nuclear imaging scans all may play a role in the diagnostic evaluation of a patient with HIV and pulmonary symptoms. (See
         <a class="local">
          'Imaging studies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Plain chest radiography is an appropriate initial imaging study for those who present with unexplained pulmonary or constitutional symptoms. Chest CTs are more sensitive than plain chest radiographs in the detection of early interstitial lung disease, lymphadenopathy, and nodules. (See
         <a class="local">
          'Chest radiography'
         </a>
         above and
         <a class="local">
          'Chest CT'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Additional evaluation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Physiologic studies
         </strong>
         – Physiologic studies, such as measurements of pulmonary function and gas exchange, may be useful for diagnosis of certain pulmonary diseases (eg, PCP), especially when chest radiographs are normal. (See
         <a class="local">
          'Physiologic studies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Sputum analysis
         </strong>
         – Analysis of spontaneously expectorated sputum is used primarily for the diagnosis of bacterial infections or TB. (See
         <a class="local">
          'Sputum analysis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Noninvasive testing
         </strong>
         – A variety of noninvasive diagnostic tests have been used in specific clinical settings. These include antigen tests and testing for beta-D-glucan to help diagnose fungal infections, and the use of polymerase chain reaction (PCR) testing to diagnose viral infections and PCP. (See
         <a class="local">
          'Noninvasive tests'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Invasive tests
         </strong>
         – On rare occasion, invasive diagnostic tests may be needed to help in the evaluation of patients with HIV and pulmonary disease. The major invasive tests include fiberoptic bronchoscopy (FOB), transbronchial cryobiopsy, CT-guided transthoracic needle aspiration (TTNA), and surgical lung biopsy using either video-assisted thoracoscopic surgery (VATS) or open thoracotomy. (See
         <a class="local">
          'Invasive tests'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3194633535">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate gratefully acknowledges John G Bartlett, MD (deceased), who contributed as Section Editor on earlier versions of this topic and was a founding Editor-in-Chief for UpToDate in Infectious Diseases.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Jones JL, Hanson DL, Dworkin MS, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ 1999; 48:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Twenty-five years of HIV/AIDS--United States, 1981-2006. MMWR Morb Mortal Wkly Rep 2006; 55:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Cock KM, Jaffe HW, Curran JW. Reflections on 40 Years of AIDS. Emerg Infect Dis 2021; 27:1553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beyrer C. A pandemic anniversary: 40 years of HIV/AIDS. Lancet 2021; 397:2142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beck JM, Rosen MJ, Peavy HH. Pulmonary complications of HIV infection. Report of the Fourth NHLBI Workshop. Am J Respir Crit Care Med 2001; 164:2120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyton RJ. Infectious lung complications in patients with HIV/AIDS. Curr Opin Pulm Med 2005; 11:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanmogne GD. Noninfectious pulmonary complications of HIV/AIDS. Curr Opin Pulm Med 2005; 11:208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leung JM. HIV and chronic lung disease. Curr Opin HIV AIDS 2023; 18:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoll M, Schmidt RE. Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART. Curr HIV/AIDS Rep 2004; 1:122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grubb JR, Moorman AC, Baker RK, Masur H. The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy. AIDS 2006; 20:1095.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sullivan JH, Moore RD, Keruly JC, Chaisson RE. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med 2000; 162:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hull MW, Phillips P, Montaner JS. Changing global epidemiology of pulmonary manifestations of HIV/AIDS. Chest 2008; 134:1287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grønborg HL, Jespersen S, Hønge BL, et al. Review of cytomegalovirus coinfection in HIV-infected individuals in Africa. Rev Med Virol 2017; 27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schneider JW, Dittmer DP. Diagnosis and Treatment of Kaposi Sarcoma. Am J Clin Dermatol 2017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vishnu P, Aboulafia DM. AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy. Adv Hematol 2012; 2012:485943.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shiels MS, Engels EA. Evolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS 2017; 12:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mena Á, Meijide H, Marcos PJ. Lung Cancer in HIV-Infected Patients. AIDS Rev 2016; 18:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Attia EF, Miller RF, Ferrand RA. Bronchiectasis and other chronic lung diseases in adolescents living with HIV. Curr Opin Infect Dis 2017; 30:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petrache I, Diab K, Knox KS, et al. HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism. Thorax 2008; 63:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pomerantz RJ. Immune reconstitution syndrome in AIDS. Interview by Vicki Glaser. AIDS Patient Care STDS 2003; 17:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matolcsy A. Primary effusional lymphoma: A new non-Hodgkin s lymphoma entity. Pathol Oncol Res 1999; 5:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khater FJ, Moorman JP, Myers JW, et al. Bronchiolitis obliterans organizing pneumonia as a manifestation of AIDS: case report and literature review. J Infect 2004; 49:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Díaz F, Collazos J, Martinez E, Mayo J. Bronchiolitis obliterans in a patient with HIV infection. Respir Med 1997; 91:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morris DG, Jasmer RM, Huang L, et al. Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence. Chest 2003; 124:929.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tobin-D'Angelo MJ, Hoteit MA, Brown KV, et al. Dapsone-induced hypersensitivity pneumonitis mimicking Pneumocystis carinii pneumonia in a patient with AIDS. Am J Med Sci 2004; 327:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Behrens GM, Stoll M, Schmidt RE. Pulmonary hypersensitivity reaction induced by efavirenz. Lancet 2001; 357:1503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morris AM, Nishimura S, Huang L. Subacute hypersensitivity pneumonitis in an HIV infected patient receiving antiretroviral therapy. Thorax 2000; 55:625.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nan DN, Fernández-Ayala M, Iglesias L, et al. Talc granulomatosis. A differential diagnosis of interstitial lung disease in HIV patients. Chest 2000; 118:258.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foulon G, Wislez M, Naccache JM, et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38:418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients. J Am Acad Dermatol 1992; 27:583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wallace JM, Hansen NI, Lavange L, et al. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 1997; 155:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crans CA Jr, Boiselle PM. Imaging features of Pneumocystis carinii pneumonia. Crit Rev Diagn Imaging 1999; 40:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levine SJ, Masur H, Gill VJ, et al. Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus. Am Rev Respir Dis 1991; 144:760.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Long R, Maycher B, Scalcini M, Manfreda J. The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1. Chest 1991; 99:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324:1644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Girardi E, Palmieri F, Cingolani A, et al. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 26:326.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones BE, Young SM, Antoniskis D, et al. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148:1292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gold JA, Rom WN, Harkin TJ. Significance of abnormal chest radiograph findings in patients with HIV-1 infection without respiratory symptoms. Chest 2002; 121:1472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aviram G, Boiselle PM. Imaging features of bacterial respiratory infections in AIDS. Curr Opin Pulm Med 2004; 10:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cordero E, Pachón J, Rivero A, et al. Haemophilus influenzae pneumonia in human immunodeficiency virus-infected patients. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Clin Infect Dis 2000; 30:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baril L, Astagneau P, Nguyen J, et al. Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: a clinical, radiological, microbiological, and epidemiological study. Clin Infect Dis 1998; 26:964.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arlotti M, Zoboli G, Moscatelli GL, et al. Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases. Scand J Infect Dis 1996; 28:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hsueh PR, Hung CC, Teng LJ, et al. Report of invasive Rhodococcus equi infections in Taiwan, with an emphasis on the emergence of multidrug-resistant strains. Clin Infect Dis 1998; 27:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torres-Tortosa M, Arrizabalaga J, Villanueva JL, et al. Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients: a multicenter study of 67 cases. Chest 2003; 123:1970.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knollmann FD, Grünewald T, Neitzert J, et al. Thoracic computed tomography of patients infected with the human immunodeficiency virus: relevance for the course of disease. J Thorac Imaging 1999; 14:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jasmer RM, Edinburgh KJ, Thompson A, et al. Clinical and radiographic predictors of the etiology of pulmonary nodules in HIV-infected patients. Chest 2000; 117:1023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bazot M, Cadranel J, Benayoun S, et al. Primary pulmonary AIDS-related lymphoma: radiographic and CT findings. Chest 1999; 116:1282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jasmer RM, Gotway MB, Creasman JM, et al. Clinical and radiographic predictors of the etiology of computed tomography-diagnosed intrathoracic lymphadenopathy in HIV-infected patients. J Acquir Immune Defic Syndr 2002; 31:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hidalgo A, Falcó V, Mauleón S, et al. Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non- Pneumocystis carinii pneumonia in AIDS patients. Eur Radiol 2003; 13:1179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen P, Knapp-Wachsner A, Hsieh CG, Kamangar N. Pulmonary Kaposi Sarcoma without Mucocutaneous Involvement: The Role of Sequential Thallium and Gallium Scintigraphy. J Clin Imaging Sci 2019; 9:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Doherty MJ, Barrington SF, Campbell M, et al. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 1997; 38:1575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith DE, Forbes A, Davies S, et al. Diagnosis of Pneumocystis carinii pneumonia in HIV antibody positive patients by simple outpatient assessments. Thorax 1992; 47:1005.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stover DE, Greeno RA, Gagliardi AJ. The use of a simple exercise test for the diagnosis of Pneumocystis carinii pneumonia in patients with AIDS. Am Rev Respir Dis 1989; 139:1343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stover DE, White DA, Romano PA, et al. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med 1985; 78:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang L, Stansell J, Osmond D, et al. Performance of an algorithm to detect Pneumocystis carinii pneumonia in symptomatic HIV-infected persons. Pulmonary Complications of HIV Infection Study Group. Chest 1999; 115:1025.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garbino J, Inoubli S, Mossdorf E, et al. Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection. AIDS 2008; 22:701.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guegan H, Robert-Gangneux F. Molecular diagnosis of Pneumocystis pneumonia in immunocompromised patients. Curr Opin Infect Dis 2019; 32:314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Helweg-Larsen J, Jensen JS, Benfield T, et al. Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples. J Clin Microbiol 1998; 36:2068.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hviid CJ, Lund M, Sørensen A, et al. Detection of Pneumocystis jirovecii in oral wash from immunosuppressed patients as a diagnostic tool. PLoS One 2017; 12:e0174012.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990; 69:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zaman MK, White DA. Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia. Diagnostic and prognostic significance. Am Rev Respir Dis 1988; 137:796.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161:1376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Narayanswami G, Salzman SH. Bronchoscopy in the human immunodeficiency virus-infected patient. Semin Respir Infect 2003; 18:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salzman SH. Bronchoscopic techniques for the diagnosis of pulmonary complications of HIV infection. Semin Respir Infect 1999; 14:318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salzman SH, Schindel ML, Aranda CP, et al. The role of bronchoscopy in the diagnosis of pulmonary tuberculosis in patients at risk for HIV infection. Chest 1992; 102:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kennedy DJ, Lewis WP, Barnes PF. Yield of bronchoscopy for the diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Chest 1992; 102:1040.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson C, Inhaber N, Menzies D. Comparison of sputum induction with fiber-optic bronchoscopy in the diagnosis of tuberculosis. Am J Respir Crit Care Med 1995; 152:1570.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hayner CE, Baughman RP, Linnemann CC Jr, Dohn MN. The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV. Chest 1995; 107:735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wallace JM, Hannah J. Cytomegalovirus pneumonitis in patients with AIDS. Findings in an autopsy series. Chest 1987; 92:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uberti-Foppa C, Lillo F, Terreni MR, et al. Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease. Chest 1998; 113:919.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Millar AB, Patou G, Miller RF, et al. Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger? Am Rev Respir Dis 1990; 141:1474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miles PR, Baughman RP, Linnemann CC Jr. Cytomegalovirus in the bronchoalveolar lavage fluid of patients with AIDS. Chest 1990; 97:1072.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mann M, Shelhamer JH, Masur H, et al. Lack of clinical utility of bronchoalveolar lavage cultures for cytomegalovirus in HIV infection. Am J Respir Crit Care Med 1997; 155:1723.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joos L, Chhajed PN, Wallner J, et al. Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients. Respir Med 2007; 101:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clarke JR, Fleming J, Donegan K, et al. Effect of HIV-1 and cytomegalovirus in bronchoalveolar lavage cells on the transfer factor for lung carbon monoxide in AIDS patients. AIDS 1991; 5:1333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobson MA, Mills J, Rush J, et al. Morbidity and mortality of patients with AIDS and first-episode Pneumocystis carinii pneumonia unaffected by concomitant pulmonary cytomegalovirus infection. Am Rev Respir Dis 1991; 144:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan SK, Burgener EB, Waggoner JJ, et al. Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis. Open Forum Infect Dis 2016; 3:ofv212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Si MW, Jagirdar J, Zhang YJ, et al. Detection of KSHV in transbronchial biopsies in patients with Kaposi sarcoma. Appl Immunohistochem Mol Morphol 2005; 13:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lentz RJ, Argento AC, Colby TV, et al. Transbronchial cryobiopsy for diffuse parenchymal lung disease: a state-of-the-art review of procedural techniques, current evidence, and future challenges. J Thorac Dis 2017; 9:2186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gruden JF, Klein JS, Webb WR. Percutaneous transthoracic needle biopsy in AIDS: analysis in 32 patients. Radiology 1993; 189:567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fitzgerald W, Bevelaqua FA, Garay SM, Aranda CP. The role of open lung biopsy in patients with the acquired immunodeficiency syndrome. Chest 1987; 91:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trachiotis GD, Hafner GH, Hix WR, Aaron BL. Role of open lung biopsy in diagnosing pulmonary complications of AIDS. Ann Thorac Surg 1992; 54:898.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3721 Version 16.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12412613" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16741493" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Twenty-five years of HIV/AIDS--United States, 1981-2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34013858" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Reflections on 40 Years of AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34087110" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : A pandemic anniversary: 40 years of HIV/AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11739145" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Pulmonary complications of HIV infection. Report of the Fourth NHLBI Workshop.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15818180" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Infectious lung complications in patients with HIV/AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15818181" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Noninfectious pulmonary complications of HIV/AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36722198" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : HIV and chronic lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16091232" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16691060" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10903221" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19059959" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Changing global epidemiology of pulmonary manifestations of HIV/AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12742798" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27714898" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Review of cytomegalovirus coinfection in HIV-infected individuals in Africa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28324233" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Diagnosis and Treatment of Kaposi Sarcoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22400030" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27749369" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Evolving epidemiology of HIV-associated malignancies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27438573" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Lung Cancer in HIV-Infected Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27753690" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Bronchiectasis and other chronic lung diseases in adolescents living with HIV.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18443163" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12724004" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Immune reconstitution syndrome in AIDS. Interview by Vicki Glaser.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10393357" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Primary effusional lymphoma: A new non-Hodgkin s lymphoma entity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15236924" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Bronchiolitis obliterans organizing pneumonia as a manifestation of AIDS: case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9135857" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Bronchiolitis obliterans in a patient with HIV infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12970019" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15090757" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Dapsone-induced hypersensitivity pneumonitis mimicking Pneumocystis carinii pneumonia in a patient with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11377607" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Pulmonary hypersensitivity reaction induced by efavirenz.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10856327" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Subacute hypersensitivity pneumonitis in an HIV infected patient receiving antiretroviral therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10893392" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Talc granulomatosis. A differential diagnosis of interstitial lung disease in HIV patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14727215" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1357010" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9001292" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10514937" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Imaging features of Pneumocystis carinii pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1928945" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1984941" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2030721" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Tuberculosis in patients with human immunodeficiency virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11317073" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7902049" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12006431" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Significance of abnormal chest radiograph findings in patients with HIV-1 infection without respiratory symptoms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15071369" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Imaging features of bacterial respiratory infections in AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10722428" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Haemophilus influenzae pneumonia in human immunodeficiency virus-infected patients. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9564484" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: a clinical, radiological, microbiological, and epidemiological study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8953675" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9709889" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Report of invasive Rhodococcus equi infections in Taiwan, with an emphasis on the emergence of multidrug-resistant strains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12796176" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients: a multicenter study of 67 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10404504" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Thoracic computed tomography of patients infected with the human immunodeficiency virus: relevance for the course of disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10767234" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Clinical and radiographic predictors of the etiology of pulmonary nodules in HIV-infected patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10559088" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Primary pulmonary AIDS-related lymphoma: radiographic and CT findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12439204" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Clinical and radiographic predictors of the etiology of computed tomography-diagnosed intrathoracic lymphadenopathy in HIV-infected patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12695843" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non- Pneumocystis carinii pneumonia in AIDS patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31448163" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Pulmonary Kaposi Sarcoma without Mucocutaneous Involvement: The Role of Sequential Thallium and Gallium Scintigraphy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9379195" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : PET scanning and the human immunodeficiency virus-positive patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1494761" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Diagnosis of Pneumocystis carinii pneumonia in HIV antibody positive patients by simple outpatient assessments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2658699" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : The use of a simple exercise test for the diagnosis of Pneumocystis carinii pneumonia in patients with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2983548" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10208204" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Performance of an algorithm to detect Pneumocystis carinii pneumonia in symptomatic HIV-infected persons. Pulmonary Complications of HIV Infection Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18356599" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31107250" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Molecular diagnosis of Pneumocystis pneumonia in immunocompromised patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9650964" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28358900" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Detection of Pneumocystis jirovecii in oral wash from immunosuppressed patients as a diagnostic tool.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2233233" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3258483" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia. Diagnostic and prognostic significance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10764337" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12840788" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Bronchoscopy in the human immunodeficiency virus-infected patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10638511" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Bronchoscopic techniques for the diagnosis of pulmonary complications of HIV infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1623742" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : The role of bronchoscopy in the diagnosis of pulmonary tuberculosis in patients at risk for HIV infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1395740" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Yield of bronchoscopy for the diagnosis of tuberculosis in patients with human immunodeficiency virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7582296" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Comparison of sputum induction with fiber-optic bronchoscopy in the diagnosis of tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7874946" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3038474" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Cytomegalovirus pneumonitis in patients with AIDS. Findings in an autopsy series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9554626" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2161629" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2158878" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Cytomegalovirus in the bronchoalveolar lavage fluid of patients with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9154883" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Lack of clinical utility of bronchoalveolar lavage cultures for cytomegalovirus in HIV infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16740381" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1662958" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Effect of HIV-1 and cytomegalovirus in bronchoalveolar lavage cells on the transfer factor for lung carbon monoxide in AIDS patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1648316" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Morbidity and mortality of patients with AIDS and first-episode Pneumocystis carinii pneumonia unaffected by concomitant pulmonary cytomegalovirus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26885542" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15722795" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Detection of KSHV in transbronchial biopsies in patients with Kaposi sarcoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28840020" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Transbronchial cryobiopsy for diffuse parenchymal lung disease: a state-of-the-art review of procedural techniques, current evidence, and future challenges.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8105506" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Percutaneous transthoracic needle biopsy in AIDS: analysis in 32 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3568770" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : The role of open lung biopsy in patients with the acquired immunodeficiency syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1417282" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Role of open lung biopsy in diagnosing pulmonary complications of AIDS.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
